Sensei biotherapeutics to participate in upcoming investor conferences

Boston, aug. 30, 2023 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that company management will participate in the following investor conferences in september 2023:
SNSE Ratings Summary
SNSE Quant Ranking